Insulin like growth factor I as a cardiac hormone: Physiological and pathophysiological implications in heart disease

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 11, 1999, Pages 2049-2061

  Ren, Jun ^a   Samson, Willis K ^b   Sowers, James R ^c  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Contraction; Disease; Growth; IGF 1

Indexed keywords

GLUCOSE; GROWTH HORMONE; INSULIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C;

ARTICLE; GLUCOSE METABOLISM; HEART DEVELOPMENT; HEART EJECTION FRACTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART STROKE VOLUME; HUMAN; INSULIN SENSITIVITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0345633539     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1999.1036     Document Type: Article

References (104)

1. Amato G, Carella C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Moni L, Saccà L, BellaÍstella A. Body composition, bone metabolism, heart structure and function in growth hormone deficient adults before and after growth hormone replacement therapy at low doses. J Clin Endocrinol Metab. 77:1993;1671-1676.
2. Andronico G, Mangano MT, Nardi B, Mule G, Piazza G, Censola G. Insulin-like growth factior I and soduim-lithium countertransoprt in essential hypertension and in hypertensive left ventricular hypertrophy. J Hypertens. 11:1993;1097-1101.
3. Anversa P, Olivetti G, Leri A, Liu Y, Kajstura J. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens. 6:1997;169-176.
4. Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell. 75:1993;73-82.
5. Begum N, Sussman KE, Draznin B. Differential effects of diabetes on adipocyte and liver phosÍphotyrosine and phosphoserine phosphatase activities. Diabetes. 40:1991;1620-1629.
6. Bereket A, Lang CH, Wilson TA. Alterations in the growth hormone-insulin-like growth factor axis in insulin dependent diabetes mellitus. Horm Metab Res. 31:1999;172-181.
7. Bernstein D, Jasper JR, Rosenfeid RG, Hintz RL. Decreased serum insulin-like growth factor-1 associated with growth failure in newborn lambs with experimental cyanotic heart disease. J Clin Invest. 89:1992;1128-1132.
8. Boger RH, Skamira C, Bode-Boger SM, Brabant G, von zur Muhlen A, Frolich JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest. 98:1996;2706-2713.
9. Bornfeldt KE, Skottner A, Arnqvist HJ. In-vivo regulation of messenger RNA encoding insulin-like growth factor-I (IGF-I) and its receptor by diabetes, insulin and IGF-1 in rat muscle. J Endocrinol. 135:1992;203-211.
10. Buerke M, Murohara T, Skurk C, Nuss C, Tomaselli K, Lefer AM. Cardioprotective effect of insulin-like growth factor I in myocardial ischemia followed by reperfusion. Proc Natl Acad Sci USA. 92:1995;8031-8035.
11. Chen WH, Pellegata NS, Wang PH. Coordinated effects of insulin-like growth factor I on inhibitory pathways of cell cycle progression in cultured cardiac muscle cells. Endocrinology. 136:1995;40-44.
12. Cittadini A, Cuocolo A, Merola B, Fazio S, Sabatini D, Nicolai E, Colao A, Longobardi S, Lombardi G, Saccà L. Impaired cardiac performance GH deficient adults and its improvement after GH replacement. Am J Physiol. 267:1994;E219-E225.
13. Cittadini A, Stromer H, Katz SE, Clark R, Moses AC, Morgan JP, Douglas PS. Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation. 93:1996;800-809.
14. 2+through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res. 83:1998;50-59.
15. Clemmons, DR, Busby, WH Jr, Clarke, JB, Duan, C, Arai, T, Nam, TJ, 1996, Insulin-like growth factor binding proteins and their role in controlling IGF actions. In: LeRoith D (ed.)International Symposium on the Role of Insulin-Like Growth Factors in Ovarian Physiology. Rome: Seromo Symposia Publications, 13, 24.
16. Coolican S, Samuel D, Ewton DZ, McWade FJ, Florini JR. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J Biol Chem. 272:1997;6653-6662.
17. Cox GN, McDermott MJ, Merkel E, Stroh CA, Ko SC, Squires CH, Gleason TM, Russell D. Recombinant human insulin-like growth factor (IGF)-binding protein-1 inhibits somatic growth stimulated by IGF-1 and growth hormone in hypophysectomized rats. Endocrinology. 135:1994;1913-1920.
18. Delafontaine P, Anwar A, Lou H. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor-1 receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest. 97:1996;139-145.
19. Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Res. 30:1995;825-834.
20. Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry MJ, Yonezawa K, Kasuga M, Waterfield MD. PI3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 13:1994;511-521.
21. Dohm GL, Elton CW, Raju MS, Mooney ND, Dimarchi R, Pories WJ, Flickinger SM Jr, Caro JF. IGF-1-stimulated glucose transport in human skeletal muscle and IGF-1 resistance in obesity and NIDDM. Diabetes. 39:1990;1028-1032.
22. Donath MY, Jenni R, Brunner H-P, Anrig M, Kohli S, Glatz Y, Froesch ER. Cardiovascular and metabolic effects of insulin-like growth factor I at rest and during exercise in humans. J Clin Endocrinol Metab. 81:1996;4089-4094.
23. Donath MY, Zapf J, Eppenberger-Eberhardt M, Froesch ER, Eppenberger HM. Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci USA. 91:1994;1686-1690.
24. Donath MY, Sutsch G, Yan X-W, Piva B, Brunner H-P, Glatz Y, Zapf J, Follath F, Froesch ER, Kiowski W. Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab. 83:1998a;3177-3183.
25. Donath MY, Zierhut W, Gosteli-Peter MA, Hauri C, Froesch ER, Zapf J. Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat. Eur J Endocrinol. 139:1998b;109-117.
26. Donohue TJ, Dworkin LD, Lango MN, Fliegner K, Lango RP, Benstein JA, Slater WR, Catanese VM. Induction of myocardial insulin-like growth factor-I gene expression in left ventricular hypertrophy. Circulation. 89:1994;799-809.
27. Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME. Regulation of neuronal survival by the serine-threonine protein kinase akt. Science. 257:1997;661-664.
28. Duerr RL, Huang S, Miraliakbar HR, Clark R, Chien KR, Ross J Jr. Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 95:1995;619-627.
29. Florini JR, Ewton DZ, Coolican SA. Growth hormone and insulin-like growth factor system in myogenesis. Endocrine Rev. 15:1996;481-517.
30. Flyvbjerg A, Jorgensen KD, Marshall SM, Orskov H. Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats. Am J Physiol. 260:1991;E568-E574.
31. Freestone NS, Ribaric S, Mason WT. The effect of insulin-like growth factor-1 on adult rat cardiac contractility. Mol Cell Biochem. 163/164:1996;223-229.
32. Fuller J, Mynett JR, Sugden PH. Stimulation of cardiac protein synthesis by insulin-like growth factors. Biochem J. 282:1992;85-90.
33. Guller H, Zapf J, Scheiwiller E, Froesch ER. Recombinant human insulin-like growth factors I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA. 85:1988;4889-4893.
34. +-channel expression of cultured neonatal rat ventricular myocytes. Am J Physiol. 272:1997;H2599-H25606.
35. +channel expression differentially in cultured newborn rat ventricular cells. Pflügers Arch. 436:1998;26-32.
36. Guron G, Friberg P, Wickmam A, Brantsing C, Gabrielsson B, Isgaard J. Cardiac insulin-like growth factor I and growth hormone receptor expression in renal hypertension. Hypertension. 27:1996;636-642.
37. Guse AH, Kiess W, Funk B, Kessler U, Berg I, Gercken G. Identification and characterization of insulin-like growth factor receptors on adult rat cardiac myocytes: linkage to inositol 1, 4, 5-trisphosphate formation. Endocrinology. 130:1992;145-151.
38. Haskell JF, Tucker D. Binding of insulin-like growth factors (IGF-1 and IGF-II) to the IGF-II/mannose 6-phosphate receptor in fetal rat myocardium. Endocrinology. 135:1994;231-239.
39. Hayakawa H, Raij L. The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension. Hypertension. 29:1997;235-241.
40. Hill CS, Treisman R. Transcriptional regulation by extracellular signals: mechanisms and specificity. Cell. 80:1995;199-211.
41. Hofmann PA, Miller WP, Moss RL. Altered calcium sensitivity of isometric tension in myocyte-sized preparations of porcine postischemic stunned myocardium. Circ Res. 72:1993;50-56.
42. Isgaard J, Tivesten A, Friberg P, Bengtsson BA. The role of the GH/IGF-I axis for cardiac function and structure. Horm Metab Res. 31:1999;50-54.
43. Ishikawa Y, Homcy CJ. The adenylyl cyclases as integrators of transmembrane signal transduction. Circ Res. 80:1997;297-304.
44. Ito H, Iroe M, Hirata Y, Tsujino M, Adachi S, Schichiri M, Koike A, Nogami A, Marumo F. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 87:1993;1715-1721.
45. Jhun BH, Meinkoth JL, Leitner JW, Draznin B, Olefsky JM. Insulin and insulin-like growth factor-1 signal transduction requires p21 ras. J Biol Chem. 269:1994;5699-5704.
46. Jiang X, Srinivasan SR, Dalferes ER Jr, Berenson GS. Plasma insulin-like growth factor 1 distribution and its relation to blood pressure in adolescents. Am J Hypertens. 10:1997;714-719.
47. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrinol Rev. 16:1995;3-34.
48. Juul A, Bang P, Hertel NT, Main K, Dalgaard P, Jorgensen K, Muller J, Hall K, Skakkebaek NE. Serum insulin-like growth factor-1 in 1030 healthy children, adolescents and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab. 78:1994;744-752.
49. Kajstura J, Cheng W, Reiss K, Anversa P. The IGF-1-IGF-1 receptor system modulates myocyte proliferation but not myocyte cellular hypertrophy in vitro. Exp Cell Res. 215:1994;273-283.
50. Kenner KA, Hill DE, Olefsky JM, Kusari J. Regulation of protein tyrosine phosphatases by insulin and insulin-like growth factor I. J Biol Chem. 268:1993;25455-25462.
51. Kolaczynski JW, Caro JF. Insulin-like growth factor-1 therapy in diabetes: physiologic basis, clinical benefits and risks. Ann Intern Med. 120:1994;47-55.
52. Kolter T, Uphues I, Eckel J. Molecular analysis of insulin-resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol. 36:1997;E59-E67.
53. Kratz G, Lake M, Ljungstrom K, Forsberg G, HegerÍstrand A, Gidlung M. Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-1 but not IGF-2-induced cell proliferation. Exp Cell Res. 202:1992;381-385.
54. Lakatta EG. Aging and cardiovascular structure and function in healthy sedentary humans. Aging. 10:1998;162-164.
55. Leaman DW, Simmen FA, Ramsay TG, White M. Insulin-like growth factor-1 and -II messenger RNA expression in muscle, heart, and liver of streptozotocin-diabetic swine. Endocrinology. 126:1990;2850-2857.
56. Lembo G, Rockman HA, Hunter JJ, Steinmetz H, Koch WJ, Ma L, Prinz MP, Ross J Jr, Chien KR, Powell- Braxton L. Elevated blood pressure and enhanced myocardial contractility in mice with severe IGF-1 deficiency. J Clin Invest. 98:1996;2648-2655.
57. Lemne C, Brismar K. Insulin-like growth factor binding protein-1 as a marker of the metabolic syndrome - a study in borderline hypertension. Blood Pressure. 7:1998;89-95.
58. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev. 16:1995;143-159.
59. LeRoith D. Insulin-like growth factors. N Engl J Med. 336:1997;633-640.
60. Li Q, Li B, Wang X, Leri A, Jana KP, Liu Y, Kajstura J, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J Clin Invest. 100:1997;1991-1999.
61. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. Mice carrying null mutation genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (IGF-1R). Cell. 75:1993;59-72.
62. Long CS, Henrich CJ, Simpson PC. A growth factor for cardiac myocytes is produced by cardiac nonmyocytes. Cell Regul. 2:1991;1081-1095.
63. MacLellan WR, Schneider MD. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res. 81:1997;137-144.
64. Marin P, Kvist H, Lindstedt G, Sjostrom L, Bjorntorp P. Low concentrations of insulin growth factor-1 in abdominal obesity. Int J Obes Relat Metab Disord. 17:1993;83-89.
65. Mathews LS, Norstedt G, Palmiter RD. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc Natl Acad Sci USA. 83:1986;9343-9347.
66. Mathews LS, Hammer RE, Behringer RR, D'Ercole AJ, Bell GI, Brinster RL, Palmiter RD. Growth enhancement of transgenic mice expressing human insulin-like growth factor I. Endocrinology. 123:1988;2827-2833.
67. Melian E, Velasco B, Barrios R, Sanchez-Franco F. Basal and growth hormone-induced hepatic messenger ribonucleic acid expression of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 is independent of hyperinsulinemia and increased energy status in the genetically obese Zucker rat. Endocrinology. 138:1997;1066-1071.
68. Mendez R, Myers MG, White MF, Rhoads RE. Stimulation of protein synthesis, eukaryotic translation initiation factor 4E phosphorylation, and PHAS-I phosphorylation by insulin requires insulin receptor substrate 1 and phosphatidylinositol 3-kinase. Mol Cell Biol. 16:1996;2857-2864.
69. Merola B, Cittadini A, Colao A, Fazio S, Longobardi S, Sabatini D, Saccà L, Lombardi G. Cardiac structural and functional abnormalities in GH-deficient adults. J Clin Endocrinol Metab. 77:1993;1658-1661.
70. Moses AC, Young SCJ, Morrow LA, O'Brian M, Clemmons DR. Recombinant human insulin-like growth factor-I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes. 45:1996;91-100.
71. Niebauer J, Pflaum CD, Clark AL, Strasburger CJ, Hooper J, Poole-Wilson PA, Coats AJ, Anker SD. Deficient insulin-like growth factor I in chronic heart failure predicts altered body composition, anabolic deficiency, cytokine and neurohormonal activation. J Am Coll Cardiol. 32:1998;393-397.
72. O'Connor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA. Identification of domains of the insulin-like growth factor I receptors that are required for protection from apoptosis. Mol Cell Biol. 17:1997;427-435.
73. Okada T, Kawano Y, Sakakibara T, Hazeki D, Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor Wortmannin. J Biol Chem. 269:1994;3568-3573.
74. Parker TG, Packer SE, Schneider MD. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J Clin Invest. 85:1990;507-514.
75. Parrizas M, LeRoith D. Insulin-like growth factor-1 inhibition of apoptosis is associated with increased expression of the bcl-xL gene product. Endocrinology. 138:1997;1355-1358.
76. Parrizas M, Sahel A, LeRoith D. Insulin-like growth factor-1 inhibits apoptosis using the PI3-kinase and mitogen-activated protein kinase pathway. J Biol Chem. 272:1997;154-161.
77. Piedras-Renteria ES, Chen CC, Best PM. Antisense oligonucleotides against rat brain alpha1E DNA and its atrial homologue decrease T-type calcium current in atrial myocytes. Proc Natl Acad Sci USA. 94:1997;14936-14941.
78. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart T. IGF-1 is required for normal embryonic growth in mice. Genes Dev. 7:1993;2609-2617.
79. Rechler MM. Editorial: Growth inhibition by insulin-like growth factor (IGF) binding protein-3. What's IGF got to do with it? Endocrinology. 138:1997;2645-2647.
80. Rechler MM. Non-receptor-binding proteins for insulin-like growth factors and other cytokines: modulation of peptide action. In: Weintraub BD (ed.) Molecular Endocrinology: Basic Concepts and Clinical Correlation. New York: Raven Press Ltd. 1995;155-180.
81. Redaelli G, Malhotra A, Li B, Li P, Sonnenblick EH, Hofmann PA, Anversa P. Effects of constitutive overexpression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circ Res. 82:1998;594-603.
82. Reiss K, Cheng W, Kajstura J, Sonnenblick EH, Meggs LG, Anversa P. Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors. Am J Physiol. 269:1995;H943-H951.
83. Reiss K, Cheng W, Ferber A, Kajstura J, Li P, Li B, Olivetti G, Homcy CJ, Baserga R, Anversa P. Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transÍgenic mice. Proc Natl Acad Sci USA. 93:1996;8630-8635.
84. Reiss K, Meggs LG, Li P, Olivetti G, Capasso JM, Anversa P. Upregulation of IGF1, IGF-1 receptor, and late growth related genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol. 158:1994;160-168.
85. 2+and nitric oxide. Am J Physiol. 275:1998;H823-H830.
86. Ren J, Sowers JR, Natavio M, Brown RA. Influence of age on iontropic response to insulin and insulin-like growth factor I in spontaneously hypertensive rats: role of nitric oxide. Proc Soc Exp Biol Med. 221:1999a;46-52.
87. Ren J, Walsh MF, Jefferson L, Brown RA, Sowers JR. Reduced cardiac contractile response to insulin-like growth factor I in obese Zucker rats (abstract). FASEB J. 13:1999b;A766.
88. Rubin R, Baserga R. Insulin-like growth factor-I receptor. Lab Invest. 73:1995;311-331.
89. Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev. 15:1994;555-573.
90. Shahi M, Beshyah SA, Hackett D, Sharp PS, Johnson DG, Foale RA. Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality. Br Heart J. 67:1992;92-96.
91. 2+channels by IGF1. Biochem Biophys Res Commun. 252:1998;151-155.
92. Sowers JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension. 29:1997;691-699.
93. 2+and nitric oxide in diabetes. In: Levin ER, Nadler JL (eds) Endocrinology of Cardiovascular Function. Boston: Kluwer Academic Publishers. 1998a;139-158.
94. Sowers JR. Obesity and cardiovascular disease. Clin Chem. 44:1998b;1821-1825.
95. Strang KT, Sweitzer NK, Greaser ML, Moss RL. β-Adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ Res. 74:1994;542-549.
96. Touyz RM, Schiffrin EL. Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase C-linked pathways. Hypertension. 30:1997;1440-1447.
97. Valensise H, Liu YY, Federici M, Lauro D, Dell'anna D, Romanini C, Sesti G. Increased expression of low-affinity insulin receptor isoform and insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension. Diabetologia. 39:1996;952-960.
98. Walsh MF, Barazi M, Pete G, Muniyappa R, Dunbar JC, Sowers JR. Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology. 137:1996;1798-1803.
99. Wang J, Niu W, Nikiforov Y, Naito S, Chernausik S, Witte D, LeRoith D, Staruch A, Fagin A. Targeted overpression of IGF-1 evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J Clin Invest. 100:1997;1425-1439.
100. Wang L, Ma W, Markovich R, Chen JW, Wang PH. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res. 83:1998;516-522.
101. Wang PH. Insulin-like growth factor 1 and the heart. In: Levin ER, Nadler JL (eds) Endocrinology of Cardiovascular Function. Boston: Kluwer Academic Publishers. 1998;225-234.
102. Wickman A, Friberg P, Adams MA, Matejka GL, Brantsing C, Guron G, Isgaard J. Induction of growth hormone receptor and insulin-like growth factor-I mRNA in aorta and caval vein during hemodymanic challenge. Hypertension. 29:1997;123-130.
103. Yamauchi K, Holt K, Pessin JE. PhosphatÍidylinositol 3-kinase functions. Upstream of Ras and Raf in mediating insulin stimulation of c-fos transcripÍtion. J Biol Chem. 268:1993;14597-14600.
104. Zenobi PD, Graf S, Ursprung H, Froesch RE. Effects of insulin-like growth factor-1 on glucose tolerance, insulin levels and insulin secretion. J Clin Invest. 89:1992;1908-1913.